Cargando…
Recent advances in treatment for narcolepsy
Narcolepsy type 1 (NT1) is a chronic orphan disorder, caused by the selective and irreversible loss of hypocretin/orexin (ORX) neurons, by a probable autoimmune process. Little is known about NT2 etiology and prevalence, sharing with NT1 excessive daytime sleepiness (EDS) and dysregulation of rapid...
Autores principales: | Barateau, Lucie, Dauvilliers, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767718/ https://www.ncbi.nlm.nih.gov/pubmed/31632459 http://dx.doi.org/10.1177/1756286419875622 |
Ejemplares similares
-
Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020) -
Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and
Histamine in Narcolepsy
por: Lopez, Régis, et al.
Publicado: (2017) -
[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2017) -
Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
por: Ayoub, Ikram, et al.
Publicado: (2023) -
CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome
por: Barateau, Lucie, et al.
Publicado: (2020)